학술논문

Activation of STING by the novel liposomal TLC388 enhances the therapeutic response to anti-PD-1 antibodies in combination with radiotherapy
Document Type
Article
Source
In: Cancer Immunology, Immunotherapy. (Cancer Immunology, Immunotherapy, May 2024, 73(5))
Subject
Language
English
ISSN
14320851
03407004